In addition, when evaluated with a three-dimensional volume reduction using 50% of the PR/SD border, significant differences in the tumor response rate to EC and DOC were observed between Rad51-positive and Rad51-negative baseline foci groups. This evidence concerns the gene RAD51 and neoplasm.